# Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System

> **NCT03889093** · NA · TERMINATED · sponsor: **University of Minnesota** · enrollment: 14 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Secondary Malignant Neoplasm of Liver

## Interventions

- **OTHER:** Yttrium-90

## Key facts

- **NCT ID:** NCT03889093
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-09
- **Primary completion:** 2022-02-24
- **Final completion:** 2022-02-24
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** PI Left Institution
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03889093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03889093, "Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03889093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*